AxoGen, Inc.
AXGN
$28.22
-$0.31-1.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 214.71M | 203.27M | 194.52M | 187.34M | 180.86M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 214.71M | 203.27M | 194.52M | 187.34M | 180.86M |
| Cost of Revenue | 54.19M | 52.31M | 50.23M | 45.36M | 44.43M |
| Gross Profit | 160.52M | 150.96M | 144.29M | 141.98M | 136.42M |
| SG&A Expenses | 129.37M | 122.61M | 118.23M | 117.50M | 116.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 210.77M | 201.56M | 194.91M | 190.63M | 189.35M |
| Operating Income | 3.94M | 1.71M | -388.00K | -3.29M | -8.50M |
| Income Before Tax | -2.10M | -4.66M | -7.16M | -9.96M | -14.31M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.10 | -4.66 | -7.16 | -9.96 | -14.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.10M | -4.66M | -7.16M | -9.96M | -14.31M |
| EBIT | 3.94M | 1.71M | -388.00K | -3.29M | -8.50M |
| EBITDA | 10.89M | 8.65M | 6.56M | 3.45M | -1.85M |
| EPS Basic | -0.05 | -0.10 | -0.16 | -0.23 | -0.33 |
| Normalized Basic EPS | -0.03 | -0.07 | -0.10 | -0.14 | -0.21 |
| EPS Diluted | -0.05 | -0.11 | -0.16 | -0.23 | -0.33 |
| Normalized Diluted EPS | -0.03 | -0.07 | -0.10 | -0.14 | -0.21 |
| Average Basic Shares Outstanding | 182.64M | 180.03M | 177.68M | 175.71M | 173.88M |
| Average Diluted Shares Outstanding | 190.34M | 185.13M | 180.86M | 178.89M | 173.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |